NHS National Pharmaceuticals Transition 2022_2

Tender description

Invitation to offer for NHS National Pharmaceuticals Transition 2022_2<br/>Offer reference number: CM/PHG/22/5655<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.<br/>Potential periods of call-offs under the framework agreement:<br/>Transition: CESW: 01/12/2022 to 30/09/2023 (10 months)<br/>LSNE: 01/12/2022 to 31/05/2024 (18 months)<br/>NWLN: 01/12/2022 to 31/05/2023 (6 months) Lot 1: Invitation to offer for NHS National Pharmaceuticals Transition 2022_2<br/>Offer reference number: CM/PHG/22/5655<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.<br/>Potential periods of call-offs under the framework agreement:<br/>Transition:<br/>CESW: 01/12/2022 to 30/09/2023 (10 months)<br/>LSNE: 01/12/2022 to 31/05/2024 (18 months)<br/>NWLN: 01/12/2022 to 31/05/2023 (6 months) Lot 1: Invitation to offer for NHS National Pharmaceuticals Transition 2022_2<br/>Offer reference number: CM/PHG/22/5655<br/>Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum contract length of 48 months.<br/>Potential periods of call-offs under the framework agreement:<br/>Transition:<br/>CESW: 01/12/2022 to 30/09/2023 (10 months)<br/>LSNE: 01/12/2022 to 31/05/2024 (18 months)<br/>NWLN: 01/12/2022 to 31/05/2023 (6 months)